ISSCR News
The ISSCR Joins Coalition Letter Urging Full-Year Funding for the National Institutes of Health (NIH)
The ISSCR joined over 450 scientific and patient advocacy organizations urging U.S. congressional leaders to finalize fiscal year 2027 appropriations for NIH as expeditiously as possible. Timely appropriations decisions are vital to ensuring critical biomedical research supported by NIH does not experience funding delays or gaps. The letter further urges lawmakers to safeguard research funding from recently proposed policies that could negatively impact biomedical research.
The ISSCR Launches New CDMO Directory to Support Stem Cell Research and Clinical Translation
New member resource connects researchers with manufacturing expertise, advancing the ISSCR’s commitment to clinical readiness and responsible translation of stem cell research
The International Society for Stem Cell Research (ISSCR) today announced the launch of its new ISSCR CDMO Directory, a web-based screening resource designed to help researchers identify contract development and manufacturing organizations (CDMOs) with capabilities relevant to advancing stem cell research toward clinical applications.
Available to the ISSCR’s nearly 5,000 members worldwide, the directory provides a centralized resource for exploring manufacturing capabilities of potential partners. The initiative reflects the Society’s strategic commitment to strengthening clinical readiness and providing researchers with practical tools and resources to help navigate the complex path from scientific discovery to clinical translation.
ISSCR 2027 Annual Meeting Opens Registration and Abstract Submissions
The field’s premier convening returns to San Francisco, 15-18 June 2027, spanning breakthroughs in basic biology, advances in disease modeling and drug discovery, and new clinical data on cell-based therapies, with AI advancing work across all three.
The International Society for Stem Cell Research (ISSCR) has opened registration and abstract submissions for the ISSCR 2027 Annual Meeting, taking place 15-18 June 2027 at Moscone West in San Francisco, California, USA. Marking the 25th anniversary of the ISSCR Annual Meeting, this hallmark event will bring together the global stem cell community to share groundbreaking discoveries, explore transformative technologies, and advance the future of stem cell science and regenerative medicine.
The ISSCR Introduces CDMO Directory, a Screening Tool to Support Researchers Advancing Toward Clinical Translation
The International Society for Stem Cell Research (ISSCR) is developing a new CDMO Directory, a web-based resource designed to help Society members identify contract development and manufacturing organizations (CDMOs) with capabilities relevant to their research and clinical translation needs.
Led by the ISSCR Manufacturing, Clinical Translation, and Regulatory (MCTR) Committee, the directory is intended to help bridge the gap between researchers and manufacturers by consolidating key information about participating CDMOs in one centralized resource. The directory will be available to the ISSCR’s nearly 5,000 members across the world staring on 19 October.
CDMOs may participate in the directory by completing a questionnaire developed to capture information researchers consider important when selecting a manufacturing partner. Responses are used to populate each organization’s profile. Through the CDMO Directory, the ISSCR is providing researchers moving toward clinical translation with a practical resource for exploring manufacturing capabilities and beginning conversations with potential partners.
The ISSCR Responds to FDA’s Draft Guidance on Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing
On 1 September, the ISSCR submitted comments to the Food and Drug Administration’s draft guidance for Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing. ISSCR supports FDA’s desire to share the Agency’s current thinking on the type of prior knowledge (i.e., public and platform knowledge) that may be scientifically appropriate to leverage to advance product development.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .